Pharmacokinetic and pharmacodynamic data from the NEOLEV1 and NEOLEV2 studies
Sign Up to like & getrecommendations! Published in 2024 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2022-324952
Abstract: Objectives To confirm that levetiracetam (LEV) demonstrates predictable pharmacokinetics(PK) at higher doses and to study the pharmacodynamics(PD) of LEV. Design Pharmacokinetic data from the NEOLEV1 and NEOLEV2 trials were analysed using a non-linear mixed effects… read more here.
Keywords: neolev2 patients; seizure burden; data neolev1; neolev1 neolev2 ... See more keywords